| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |